Close Menu

NEW YORK (GenomeWeb) – Invitae announced after the close of the market on Tuesday that it will sell 9 million shares of its common stock at $19.00 per share.

The public offering, which Invitae announced on Monday, is expected to close on or around March 8 and bring in $171.0 million in gross proceeds, the firm said.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.